Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers

article

Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/TP.0B013E3182187CF0
P698PubMed publication ID21617590

P50authorAlessandro CucchettiQ38323998
Giorgio ErcolaniQ38324012
Gian Luca GraziQ56424514
Matteo RavaioliQ87935878
Matteo CesconQ90455067
Massimo Del GaudioQ90455071
Golfieri RitaQ98581110
Antonio Daniele PinnaQ114325333
Valentina Rosa BertuzzoQ117260468
Antonietta D'Errico-GrigioniQ117260469
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectinflammationQ101991
hepatocellular carcinomaQ1148337
liver transplantationQ1368191
P304page(s)1279-1285
P577publication date2011-06-01
P1433published inTransplantationQ15730500
P1476titleAnalysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers
P478volume91

Reverse relations

cites work (P2860)
Q38059620A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability.
Q38269467Biological markers of hepatocellular carcinoma for use as selection criteria in liver transplantation
Q39112472Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy
Q47147429Combination of the neutrophil to lymphocyte ratio and the platelet to lymphocyte ratio as a useful predictor for recurrence following radiofrequency ablation of hepatocellular carcinoma
Q48009815Combination with CK19 Might Increase the Prognostic Power of Hep Par 1 in Hepatocellular Carcinoma after Curative Resection
Q41054345Combined Hangzhou criteria with neutrophil-lymphocyte ratio is superior to other criteria in selecting liver transplantation candidates with HBV-related hepatocellular carcinoma.
Q47614432Critical evaluation of the American Joint Commission on Cancer (AJCC) 8th edition staging system for patients with Hepatocellular Carcinoma (HCC): A Surveillance, Epidemiology, End Results (SEER) analysis
Q89476590DNA methylation of SOCS1/2/3 predicts hepatocellular carcinoma recurrence after liver transplantation
Q44653651Donor factors similarly impact survival outcome after liver transplantation in hepatocellular carcinoma and non-hepatocellular carcinoma patients
Q50244060Downstaging advanced hepatocellular carcinoma to the Milan criteria may provide a comparable outcome to conventional Milan criteria
Q36406952Effects of antiviral therapy on the recurrence of hepatocellular carcinoma after curative resection or liver transplantation.
Q26769591Elevated Preoperative Neutrophil-Lymphocyte Ratio Is Associated with Poor Prognosis in Hepatocellular Carcinoma Patients Treated with Liver Transplantation: A Meta-Analysis
Q41439820Expression and Significances of G-Protein-Coupled Receptor Kinase 3 in Hepatocellular Carcinoma
Q44606962Hepatic venous congestion in living donor grafts in liver transplantation: is there an effect on hepatocellular carcinoma recurrence?
Q44696972Impact of tumor size, number of tumors and neutrophil-to-lymphocyte ratio in liver transplantation for recurrent hepatocellular carcinoma
Q44165064Inflammatory markers are associated with outcome in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization
Q28074653Liver transplantation for advanced hepatocellular carcinoma
Q38821374Liver transplantation for hepatobiliary malignancies: a new era of "Transplant Oncology" has begun
Q38177251Liver transplantation for hepatocellular carcinoma: role of inflammatory and immunological state on recurrence and prognosis
Q84496768Liver transplantation: a simple inflammation marker predicts liver cancer prognosis
Q38221424Mammalian target of rapamycin inhibitors are associated with lower rates of hepatocellular carcinoma recurrence after liver transplantation: a systematic review.
Q42333014Milan criteria and its expansions in liver transplantation for hepatocellular carcinoma
Q53548609Neutrophil-lymphocyte and platelet-lymphocyte ratio in patients after resection for hepato-pancreatico-biliary malignancies.
Q36756063Neutrophil-lymphocyte ratio predicts overall and recurrence-free survival after liver transplantation for hepatocellular carcinoma
Q37378982Neutrophil-lymphocyte ratio predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation
Q87509976Neutrophil-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma
Q39333416Neutrophil-to-lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma: a Western perspective
Q45358708Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation
Q36052780Neutrophil-to-lymphocyte ratio for the prognostic assessment of hepatocellular carcinoma: A systematic review and meta-analysis of observational studies
Q41734066Neutrophil-to-lymphocyte ratio predicts mortality in patients listed for liver transplantation
Q41544562Novel Pretreatment Scoring Incorporating C-reactive Protein to Predict Overall Survival in Advanced Hepatocellular Carcinoma with Sorafenib Treatment
Q40235716Postoperative peak serum C-reactive protein is a predictor of outcome following liver transplantation for hepatocellular carcinoma
Q37725550Pre-radiotherapy neutrophil-to-lymphocyte ratio as an independent prognostic factor in patients with locally advanced hepatocellular carcinoma treated with radiotherapy
Q26772329Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation
Q64085445Preoperative Neutrophil-to-Lymphocyte Ratio Plus Platelet-to-Lymphocyte Ratio Predicts the Outcomes after Curative Resection for Hepatocellular Carcinoma
Q33912315Preoperative Neutrophil-to-Lymphocyte Ratio as a New Prognostic Marker in Hepatocellular Carcinoma after Curative Resection.
Q50195636Pretreatment neutrophil-lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma
Q40212610Prognostic prediction of male recipients selected for liver transplantation: With special attention to neutrophil to lymphocyte ratio
Q36746912Prognostic role of C-reactive protein in hepatocellular carcinoma: a systematic review and meta-analysis
Q33589014Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis
Q35161694Prognostic significance of the neutrophil-to-lymphocyte ratio in primary liver cancer: a meta-analysis
Q31111026Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma
Q35534078Prognostic value of neutrophil distribution in cholangiocarcinoma
Q33652003Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis
Q42237455Radiological response and inflammation scores predict tumour recurrence in patients treated with transarterial chemoembolization before liver transplantation.
Q52620441Reactivation of hepatitis B after liver transplantation: Current knowledge, molecular mechanisms and implications in management.
Q38594469Recurrence of hepatocellular carcinoma after liver transplantation: an update
Q35799223Relationship of preoperative neutrophil lymphocyte ratio with prognosis in gastrointestinal stromal tumors
Q34038193Retracted: A Scoring Model Based on Neutrophil to Lymphocyte Ratio Predicts Recurrence of HBV-Associated Hepatocellular Carcinoma after Liver Transplantation
Q47649573Risk factors of early recurrence after curative hepatectomy in hepatocellular carcinoma
Q89701689Role of inflammatory markers as hepatocellular cancer selection tool in the setting of liver transplantation
Q38818641Serologic and molecular biomarkers for recurrence of hepatocellular carcinoma after liver transplantation: A systematic review and meta-analysis.
Q61443474Serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantation
Q55289894Significance of serum ferritin as a prognostic factor in advanced hepatobiliary cancer patients treated with Korean medicine: a retrospective cohort study.
Q27005375Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation
Q50158378The Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Are Prognostic Factors in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiotherapy
Q37436505The predictive value of blood neutrophil-lymphocyte ratio in patients with end-stage liver cirrhosis following ABO-incompatible liver transplantation
Q47338550The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis.
Q37001415The systemic inflammatory response as a prognostic factor for advanced hepatocellular carcinoma with extrahepatic metastasis
Q64085297Treatment selection of recurrent hepatocellular carcinoma with microvascular invasion at the initial hepatectomy
Q45405877Two-step selection criteria for living donor liver transplantation in patients with hepatocellular carcinoma
Q60932844Utility and Limitation of Preoperative Neutrophil Lymphocyte Ratio as a Prognostic Factor in Hepatocellular Carcinoma

Search more.